GB2033382A - Production of N-(4'-Chloro-3- sulphamoyl-benzenesulphonyl)-N- methyl-2-aminomethyl-2-methyl tetrahydrofuran - Google Patents

Production of N-(4'-Chloro-3- sulphamoyl-benzenesulphonyl)-N- methyl-2-aminomethyl-2-methyl tetrahydrofuran Download PDF

Info

Publication number
GB2033382A
GB2033382A GB7933926A GB7933926A GB2033382A GB 2033382 A GB2033382 A GB 2033382A GB 7933926 A GB7933926 A GB 7933926A GB 7933926 A GB7933926 A GB 7933926A GB 2033382 A GB2033382 A GB 2033382A
Authority
GB
United Kingdom
Prior art keywords
methyl
mefrusid
chloro
solution
aminomethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB7933926A
Other versions
GB2033382B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of GB2033382A publication Critical patent/GB2033382A/en
Application granted granted Critical
Publication of GB2033382B publication Critical patent/GB2033382B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The process for production of the above compound comprises reacting 4-chloro-3-sulphamoyl-benzene- sulphonic acid chloride in a chlorinated hydrocarbon solvent, with an aqueous solution (containing alkali group carbonate) of N-methyl-2- aminomethyl-2-methyl- tetrahydrofurane-ammonium hydrogen sulphate at a temperature between 20 and 100 DEG C.

Description

SPECIFICATION Production of N-(4'-chloro-3'sulphamoylbenzenesulphonyl)-N-methyl-2amino-methyl-2-methyl-tetrahydrofurane The present invention relates to an unobvious process for the production of the known compound N-(4'-chloro-3'-sulphamoyl benzenesuiphonyl )-N-methyl-2-aminomethyl-2- methyl-tetrahydrofurane and the pharmaceutical use thereof.
The above-mentioned compound is known as a diuretic agent under the generic name "Mefrusid". Hitherto, it was prepared by reacting 4-chloro-3-sulphamoyl-benzene-suíphonic acid chloride (called Sulphochloride 1 500 in the following text) with N-methyl-2-aminomethyl-2methyl-tetra-hydrofu rane-a mmonium hydrogen sulphate (called Amine Sulphate 1 500 in the following text), the reaction being carried out in a solvent mixture of methyl ethyl ketone/water or acetone/water.
In order to obtain from the resulting crude Mefrusid a pure active compound which is suitable for pharmaceutical requirements, additional purification steps were hitherto necessary. The crude product was hitherto dissolved in sodium hydroxide solution and, after treatment with active charcoal, the solution was filtered and the product was precipitated from the filtrate with ammonium chloride solution and then isolated. This purification step was followed by a further recrystallisation by dissolving the product in hot, aqueous methanol, treatment of the solution with active charcoal, filtration, renewed crystallisation and subsequent isolation of the purified active compound.
These purification operations are timeconsuming and expensive, pollute the effluent and greatly reduce the yield.
According to the present invention we provide a process for the production of a compound which is N-(4'-chloro-3'-sulphamoylbenzenesu Iphonyl)-N-methyl-2-aminomethyl-2methyl-tetrahydrofurane, in which 4-chloro-3sulphamoyl-benzene-sulphonic acid chloride is reacted, in a chlorinated hydrocarbon, with an aqueous solution, containing potassium carbonate, of N-methyl-2-aminomethyl-2-methyl- tetrahydrofurane-ammonium hydrogen sulphate at a temperature between 20 and 1000C.
A particularly preferred process for producing Mefrusid in a pure form is one in which Sulphochloride 1 500 is dissolved in a liquid chlorinated hydrocarbon, under the influence of heat, the insoluble material is filtered off and the filtrate is reacted with an aqueous potassium carbonate-Amine-Suiphate 1 500 solution at temperatures between 40 and 800 C, the chlorinated hydrocarbon is then distilled off, the precipitated Mefrusid is dissolved by heating, with the addition of a C1 to C4 alkanol, and, after filtering the mixture and cooling the solution, the Mefrusid which has crystallised out is then isolated.
The Mefrusid obtained in this manner is already so pure that, after simple, single recrystallisation in aqueous alcohol, it can be employed for the preparation of medicaments.
Chlorinated hydrocarbons which are particularly advantageous to use are chlorobenzene or, preferably, 1 ,2-dichloroethane.
Alkanols with 1 to 4 carbon atoms, in particular ethanol, or preferably methanol, are preferably used for the recrystallisation.
The reaction according to the invention is appropriately preferably carried out in a temperature range from 40 to 800C, and especially from 50 to 700C.
It is exceptionally surprising that the reaction of Sulphochloride 1 500 with potassium carbonate Amine Sulphate 1 500 can be carried out using chlorinated hydrocarbons as solvents and that such a pure Mefrusid is obtained by this procedure.
The process according to the invention has a number of advantages. Compared with the process known hitherto, changing of solvents, using active charcoal and the addition of ammonium chloride to precipitate the Mefrusid are dispensed with. Furthermore, the yield of pure Mefrusid is higher than in the case of the process known hitherto.
The following Example illustrates the process of the present invention.
Example 100 g of Sulphochloride 1 500 are dissolved in 1 880 g of 1 2-dichloroethane at the boil.
Insoluble material is filtered off from the hot solution. The filtrate is run into an aqueous solution of 160 ml of water, 70 g of potassium carbonate and 70 g of Amine Sulphate 1 500. The mixture is stirred at 50--600C for 5 hours. 300 ml of water are then added and the aqueous layer is separated off. The 1,2-dichloroethane is distilled off with steam. The 1 2-dichloroethane which has distilled off is dried with calcium chloride, after separating off the water, and is available for re-use.
The same amount by volume of methanol is added to the aqueous Mefrusid suspension, 5 10 g of active charcoal are added and the mixture is heated to the boil.
The hot solution is filtered. The Mefrusid is crystallised out from the cooled filtrate. It is filtered off and washed with 3 x 100 ml of water.
The moist Mefrusid is recrystallised once from aqueous methanol and a Mefrusid which corresponds to the purity requirements for medicaments is obtained.
Claims
1. A process for the production of a compound which is N-(4'-chloro-3'-sulphamoyl benzenesu Iphonyl)-N-methyl-2-aminomethyl-2- methyl-tetrahydrofurane, in which 4-chloro-3sulphamoyl-benzene-sulphonic acid chloride is reacted, in a chlorinated hydrocarbon, with an aqueous solution, containing alkali carbonate, of
**WARNING** end of DESC field may overlap start of CLMS **.

Claims (9)

**WARNING** start of CLMS field may overlap end of DESC **. SPECIFICATION Production of N-(4'-chloro-3'sulphamoylbenzenesulphonyl)-N-methyl-2amino-methyl-2-methyl-tetrahydrofurane The present invention relates to an unobvious process for the production of the known compound N-(4'-chloro-3'-sulphamoyl benzenesuiphonyl )-N-methyl-2-aminomethyl-2- methyl-tetrahydrofurane and the pharmaceutical use thereof. The above-mentioned compound is known as a diuretic agent under the generic name "Mefrusid". Hitherto, it was prepared by reacting 4-chloro-3-sulphamoyl-benzene-suíphonic acid chloride (called Sulphochloride 1 500 in the following text) with N-methyl-2-aminomethyl-2methyl-tetra-hydrofu rane-a mmonium hydrogen sulphate (called Amine Sulphate 1 500 in the following text), the reaction being carried out in a solvent mixture of methyl ethyl ketone/water or acetone/water. In order to obtain from the resulting crude Mefrusid a pure active compound which is suitable for pharmaceutical requirements, additional purification steps were hitherto necessary. The crude product was hitherto dissolved in sodium hydroxide solution and, after treatment with active charcoal, the solution was filtered and the product was precipitated from the filtrate with ammonium chloride solution and then isolated. This purification step was followed by a further recrystallisation by dissolving the product in hot, aqueous methanol, treatment of the solution with active charcoal, filtration, renewed crystallisation and subsequent isolation of the purified active compound. These purification operations are timeconsuming and expensive, pollute the effluent and greatly reduce the yield. According to the present invention we provide a process for the production of a compound which is N-(4'-chloro-3'-sulphamoylbenzenesu Iphonyl)-N-methyl-2-aminomethyl-2methyl-tetrahydrofurane, in which 4-chloro-3sulphamoyl-benzene-sulphonic acid chloride is reacted, in a chlorinated hydrocarbon, with an aqueous solution, containing potassium carbonate, of N-methyl-2-aminomethyl-2-methyl- tetrahydrofurane-ammonium hydrogen sulphate at a temperature between 20 and 1000C. A particularly preferred process for producing Mefrusid in a pure form is one in which Sulphochloride 1 500 is dissolved in a liquid chlorinated hydrocarbon, under the influence of heat, the insoluble material is filtered off and the filtrate is reacted with an aqueous potassium carbonate-Amine-Suiphate 1 500 solution at temperatures between 40 and 800 C, the chlorinated hydrocarbon is then distilled off, the precipitated Mefrusid is dissolved by heating, with the addition of a C1 to C4 alkanol, and, after filtering the mixture and cooling the solution, the Mefrusid which has crystallised out is then isolated. The Mefrusid obtained in this manner is already so pure that, after simple, single recrystallisation in aqueous alcohol, it can be employed for the preparation of medicaments. Chlorinated hydrocarbons which are particularly advantageous to use are chlorobenzene or, preferably, 1 ,2-dichloroethane. Alkanols with 1 to 4 carbon atoms, in particular ethanol, or preferably methanol, are preferably used for the recrystallisation. The reaction according to the invention is appropriately preferably carried out in a temperature range from 40 to 800C, and especially from 50 to 700C. It is exceptionally surprising that the reaction of Sulphochloride 1 500 with potassium carbonate Amine Sulphate 1 500 can be carried out using chlorinated hydrocarbons as solvents and that such a pure Mefrusid is obtained by this procedure. The process according to the invention has a number of advantages. Compared with the process known hitherto, changing of solvents, using active charcoal and the addition of ammonium chloride to precipitate the Mefrusid are dispensed with. Furthermore, the yield of pure Mefrusid is higher than in the case of the process known hitherto. The following Example illustrates the process of the present invention. Example 100 g of Sulphochloride 1 500 are dissolved in 1 880 g of 1 2-dichloroethane at the boil. Insoluble material is filtered off from the hot solution. The filtrate is run into an aqueous solution of 160 ml of water, 70 g of potassium carbonate and 70 g of Amine Sulphate 1 500. The mixture is stirred at 50--600C for 5 hours. 300 ml of water are then added and the aqueous layer is separated off. The 1,2-dichloroethane is distilled off with steam. The 1 2-dichloroethane which has distilled off is dried with calcium chloride, after separating off the water, and is available for re-use. The same amount by volume of methanol is added to the aqueous Mefrusid suspension, 5 10 g of active charcoal are added and the mixture is heated to the boil. The hot solution is filtered. The Mefrusid is crystallised out from the cooled filtrate. It is filtered off and washed with 3 x 100 ml of water. The moist Mefrusid is recrystallised once from aqueous methanol and a Mefrusid which corresponds to the purity requirements for medicaments is obtained. Claims
1. A process for the production of a compound which is N-(4'-chloro-3'-sulphamoyl benzenesu Iphonyl)-N-methyl-2-aminomethyl-2- methyl-tetrahydrofurane, in which 4-chloro-3sulphamoyl-benzene-sulphonic acid chloride is reacted, in a chlorinated hydrocarbon, with an aqueous solution, containing alkali carbonate, of N-methyl-2-aminomethyl-2-methyltetrahydrofurane-ammonium hydrogen sulphate at a temperature between 20 and 1 000C.
2. A process according to Claim 1, in which the alkali carbonate is potassium carbonate.
3. A process according to Claim 1, in which the chlorinated hydrocarbon is 1,2-dichloroethane.
4. A process according to Claim 1 or 2, in which the reaction is carried out at a temperature of50to700C.
5. A process according to any of Claims 1 to 3, in which the compound obtained is recrystallised from an aqueous alcohol solution.
6. A process according to Claim 4, in which the alcohol is an alkanol with 1 to 4 carbon atoms.
7. A process according to Claim 5, in which the alkanol is methanol,.
8. A process according to Claim 1, when carried out substantially as described in the Example.
9. N-(4'-chloro-3'-sulphamoylbenzenesulphonyl)-N-methyl-2-aminomethyl-2 methyl-tetrahydrofurane when produced by the process of any of the foregoing claims.
GB7933926A 1978-10-03 1979-10-01 Production of n - (4' - chloro - 3 - sulphamoylbenzenesulphonyl) - n methyl - 2 - aminomethyl- 2 - methyl tetrahydrofurane Expired GB2033382B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782843040 DE2843040A1 (en) 1978-10-03 1978-10-03 METHOD FOR PRODUCING N- (4'-CHLORINE-3'-SULFAMOYL-BENZOLSULFONYL) -N-METHYL- 2-AMINOMETHYL-2-METHYL-TETRAHYDROFURANE

Publications (2)

Publication Number Publication Date
GB2033382A true GB2033382A (en) 1980-05-21
GB2033382B GB2033382B (en) 1982-11-03

Family

ID=6051240

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7933926A Expired GB2033382B (en) 1978-10-03 1979-10-01 Production of n - (4' - chloro - 3 - sulphamoylbenzenesulphonyl) - n methyl - 2 - aminomethyl- 2 - methyl tetrahydrofurane

Country Status (4)

Country Link
JP (1) JPS5942674B2 (en)
CH (1) CH641174A5 (en)
DE (1) DE2843040A1 (en)
GB (1) GB2033382B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4503131A (en) * 1982-01-18 1985-03-05 Richardson Chemical Company Electrical contact materials
JPS59812A (en) * 1982-06-28 1984-01-06 田中貴金属工業株式会社 Brush material for slide contact
JPS59219818A (en) * 1983-05-27 1984-12-11 田中貴金属工業株式会社 Composite electric contact material

Also Published As

Publication number Publication date
DE2843040A1 (en) 1980-04-17
GB2033382B (en) 1982-11-03
JPS5549367A (en) 1980-04-09
CH641174A5 (en) 1984-02-15
DE2843040C2 (en) 1988-02-25
JPS5942674B2 (en) 1984-10-16

Similar Documents

Publication Publication Date Title
US2654779A (en) Method of preparation of guanidino fatty acids
US3084155A (en) Derivatives of dibenzo
GB2033382A (en) Production of N-(4'-Chloro-3- sulphamoyl-benzenesulphonyl)-N- methyl-2-aminomethyl-2-methyl tetrahydrofuran
US2671086A (en) 3,6-dichloro and 3,6-dibromopyridazines
JPS5855485A (en) Purification of guanine
SU880251A3 (en) Method of preparing thiochromane derivatives or their salts
US3769406A (en) Treating hyperglycemia with phosphorylated guanidines and biguanidines
US2693466A (en) Production of purified sulfamerazine
US3202712A (en) 1-cyclohexene-4-bis (omicron-chlorobenzylaminomethyl) and derivatives
Clarke The Action of Hypochlorite on Sulfanilate
CN112521298B (en) Synthesis method of lidocaine
US2447419A (en) Preparation of diphenylacetonitrile
KR910006903B1 (en) The product process of 2,2'-dihydroxy-4,4'-dialkoxybenzophenone derivatives
US3234235A (en) Heterocyclic carbinols
US2676175A (en) Process for manufacturing thiamine
US2715624A (en) Dimethyl piperazinium theophylline-7-acetate
US1930753A (en) Chlorination of cresidine
US2517496A (en) Preparation of symmetrical monoaminodihydroxytoluene
CN117658946A (en) Synthesis method of dibenzothiazyl sulfide
SU469702A1 (en) Method for preparing 4-nitro-5-aryl-1,2,3-triazole derivatives
JPS58121251A (en) Preparation of 5-(2-(dialkylamino)ethoxy)carvacrol acetate hydrochloride
JP3544694B2 (en) Method for producing N-tert-butyl-2-piperazinecarboxamides
KR900004400B1 (en) Process for the preparation of halogened carbanilide
US2133389A (en) 1'-chloro-1-methyl-5-nitronaphthalene and process for manufacturing the same
JPH04312557A (en) Method of manufacturing dialkylaminopropanediol

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee